Protalix BioTherapeutics
PLX
PLX
30 hedge funds and large institutions have $2.44M invested in Protalix BioTherapeutics in 2021 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 10 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
57% less capital invested
Capital invested by funds: $5.61M → $2.44M (-$3.17M)
77% less call options, than puts
Call options by funds: $140K | Put options by funds: $614K
Holders
30
Holding in Top 10
–
Calls
$140K
Puts
$614K
Top Buyers
| 1 | +$339K | |
| 2 | +$96.8K | |
| 3 | +$71.2K | |
| 4 |
Jane Street
New York
|
+$37.1K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$33K |
Top Sellers
| 1 | -$825K | |
| 2 | -$325K | |
| 3 | -$188K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$140K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$129K |